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Abstract
Background: Anterior cervical discectomy with fusion (ACDF) is challenging with respect to both patient selection
and choice of surgical procedure. The aim of this study was to evaluate the clinical outcome of ACDF, with respect
to both patient selection and choice of surgical procedure: fusion with an autologous iliac crest graft (AICG) versus
fusion with an artificial cage made of polyetheretherketone (PEEK).
Methods: This was a non-randomized prospective single-center outcome study of 258 patients who underwent
ACDF for cervical disc degeneration (CDD). Fusion was attained with either tricortical AICG or PEEK cages without
additional anterior plating, with treatment selected at surgeon’s discretion. Radicular pain, neck-pain, headache and
patient satisfaction with the treatment were scored using the visual analogue scale (VAS).
Results: The median age was 47.5 (28.3-82.8) years, and 44% of patients were female. 59% had single-level ACDF,
40% had two level ACDF and 1% had three-level ACDF. Of the patients, 181 were fused with AICG and 77 with a
PEEK-cage. After surgery, the patients showed a significant reduction in radicular pain (ΔVAS = 3.05), neck pain
(ΔVAS = 2.30) and headache (ΔVAS = 0.55). Six months after surgery, 48% of patients had returned to work:
however 24% were still receiving workers’ compensation.
Using univariate and multivariate analyses we found that high preoperative pain intensity was significantly asso-
ciated with a decrease in pain intensity after surgery, for all three pain categories. There were no significant correla-
tions between pain relief and the following patient characteristics: fusion method (AICG or PEEK-cage), sex, age,
number of levels fused, disc level fused, previous neck surgery (except for neck pain), previous neck trauma, or pre-
operative symptom duration. Two hundred out of the 256 (78%) patients evaluated the surgical result as successful.
Only 27/256 (11%) classified the surgical result as a failure. Patient satisfaction was significantly associated with pain
relief after surgery.
Conclusions: ACDF is an effective treatment for radicular pain in selected patients with CDD after six months
follow up.
Because of similar clinical outcomes and lack of donor site morbidity when using PEEK, we now prefer fusion with
PEEK cage to AICG.
Lengthy symptom duration was not a negative prognostic marker in our patient population.
The number of patients who returned to work 6 months after surgery was lower than expected.
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The vast majority of patients with symptomatic cervical
disc degeneration (CDD) respond well to conservative
treatment [1]. For nonresponders, surgical treatment
using ACDF is an option for selected patients [2]. In the
USA, the annual incidence of surgery for CDD is 50-60
per 100 000 inhabitants [3]. Selection of adequate candi-
dates for ACDF surgery is a continuous challenge.
According to the literature, the following are potential
positive predictive preoperative markers: intense radicu-
lar pain, low disability, young age, soft disc disease in
one segmental level, male sex, non-smoker status, pre-
sence of a correlation between radiological and clinical
findings, good hand strength, good active range of
motion in the neck, and no spinal litigations [4,5]. In
surgery for lumbar disc degeneration, symptom duration
> 6 months is regarded as a negative prognostic factor
[6]. This is also reported to be true for ACDF surgery
[7]. This is intriguing, as many patients referred to
ACDF surgery have symptom duration > 6 months. Is
surgery in these patients worthwhile or futile?
The gold standard for ACDF has been fusion with an
AICG [8-10]. This is a relatively safe procedure with few
complications [11-13]. However, this surgical procedure
has been hampered by iliac crest donor site morbidity.
This has led to a growing interest in artificial cages
made of various materials, including tantalium blocks,
titanium, carbonfiber and polyetheretherketone (PEEK),
to replace the AICG [12,14-18]. In our hospital since
2004 we have gradually shifted from AICG to PEEK.
We found no increase in complications after shifting to
fusion with a PEEK cage [11].
We prospectively registered all ACDF patients fol-
lowed in our department from 2003-2005 and used this
information to address the following questions.
1. What improvement in clinical outcomes can be
expected after ACDF for CDD with regard to radicular
pain, neck pain, headache, and return to work?
2. Did the gradual shift from fusion with AICG to
fusion with PEEK cage, in our department during the
study period, influence outcomes?
3. Do symptom duration or other preoperative clinical
variables correlate with outcome after ACDF for CDD
in our series?
Methods
This was a prospective single-center study of patients
who underwent single-, two-, or three-level ACDF for
CDD. The study was performed at the Oslo University
Hospital-Rikshospitalet in Oslo from 2003 to 2005. All
surgeons were asked to participate in a prospective
registration of clinical parameters. During this period,
390 patients (total group) were eligible for inclusion and
we obtained complete preoperative and follow-up data
for 258 patients (66.1%) (study group). Only the 258
patients with complete data sets were included in the
analysis.
Inclusion criteria (1 + 2)
The inclusion criteria were
1. One or more of the following symptoms and signs
of CDD:
a. Persistent severe radicular pain not responding to
conservative management for three months.
b. Cervical radiculopathy with progressive paresis.
c. Selected cases with myelopathy secondary to cer-
vical spinal canal stenosis that can be adequately
decompressed with ACDF.
d. Selected cases with mainly neck pain and head-
ache and less radicular pain.
2. MRI- documented CDD with compression of cervi-
cal nerve roots or spinal cord, which most likely explain
the clinical symptoms and signs.
Exclusion criteria
The exclusion criteria were
1. Cervical trauma within the past four weeks.
2. Cervical neoplasia.
3. Ongoing cervical infection.
Diagnostic work-up
The diagnostic work-up included
1. Clinical and neurological examination.
2. Cervical MRI (cervical CT-myelography was used in
one case where MRI was contraindicated due to a per-
manent pacemaker).
ACDF
In all patients, we used an anterior approach to the cer-
vical spine with a right-sided skin incision, as originally
described by Robinson and Smith [9]. A self-retractor
was mounted after verification of the levels of interest
using fluoroscopy, (Shadow -line, V. Mueller Neuro/
Spine Product, Cardinal Health, San Carlos, CA).
In most patients, an operating microscope was used
and the disc was removed with a high-speed drill (Midas
Rex, Medtronic, Memphis, TN). Removal of the posterior
longitudinal ligament and the final decompression of the
nerve roots were performed using small rongeurs. Bilat-
eral nerve root decompression was always performed,
even in patients with unilateral symptoms. After the pro-
cedure, distraction was applied using the Shadow-line
Distraction System (V. Mueller Neuro/Spine Product,
Cardinal Health). Fusion was attained with either tricorti-
cal AICG or PEEK cages (Cervios, Stratec Medical, Ober-
dorf, Switzerland), at the discretion of the surgeon. After
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were plugged with bone wax (Ethicon, Johnson & Johnson,
Somerville, NJ) to prevent postoperative bleeding. Wound
drainage was not routinely used. A single dose of cepha-
lothin (30 mg/kg), which was used as infection prophy-
laxis, was administered 15-30 min before the skin incision
[19-21].
Iliac crest auto graft
The tricortical AICG was harvested from the right iliac
crest. Care was taken to preserve the anterior 2 cm of
the iliac crest and the lateral cutaneous femoral nerve.
The bone grafts were harvested using an oscillating saw
a n dag r a f tc u t t e r ,a n dt h eb o n eb e dw a sw a x e dw i t h
bone wax (Ethicon, Johnson & Johnson, USA). Wound
drainage was not routinely used, and the surrounding
soft tissue was infiltrated with 20 ml of bupivacaine
after wound closure.
Postoperative care
The patients were observed in a recovery unit for the
first 4-6 h after surgery, and were then transferred to
the regular neurosurgical ward. All patients were mobi-
lized with a stiff collar within 24 h after surgery. Almost
all patients were discharged from our hospital to the
referring neurological department 48-72 h after surgery.
All patients were encouraged repeatedly to participate in
normal activities 6-14 weeks after surgery. A final clini-
cal examination was performed 6 months after surgery
in our outpatient clinic.
Prospective registration of clinical parameters
The parameters registered the day before surgery
included age, sex, symptom duration before surgery
(months), previous surgery for CDD, previous neck
trauma, working status, radicular pain, neck pain, head-
ache, myelopathy (yes/no), and paresis (muscular
strength graded according to the Royal Medical
Research Council of Great Britain, where 5 is normal
strength and 0 is total paralysis in the affected muscle
group)[22]. Each of the three pain categories was scored
using a VAS, where 0 indicated no pain and 10 repre-
sented extreme pain[23].
As the clinical impact of changes in VAS scores less
than ± 2 is unclear, we estimated the number of patients
that had changes in VAS scores of more than ± 2 for
the three pain categories [24,25]. The parameters regis-
tered during surgery included: number of levels fused
(single-level, two-level, or three-level fusion), level fused
(C3/C4, C4/C5, C5/C6, C6/7 or C7/Th1) and fusion
type (AICG or PEEKcage). The following parameters
were registered at the 6-month follow-up visit in our
outpatient clinic: radicular pain, neck pain, headache,
myelopathy (a diagnosis of myelopathy required
neurological signs of upper motor neuron affection as
Babinsky sign, hyperreflexia or increased muscular
tone), paresis, working status and patient satisfaction
with the surgical treatment. Patient satisfaction was
measured using a VAS scale, where a score of 0 indi-
cated that the patient was not at all satisfied with the
result of ACDF and a score of 10 indicated that the
patient was very satisfied with the surgical outcomes
[26,27]. We defined a VAS score ≥ 8 as a success, while
a score ≤ 5 was regarded as a failure.
Surgery-related complications
We have previously published our complications in 390
consecutive ACDF operations, which included 278
patients fused with AICG and 112 patients fused with a
PEEK graft [11].
Database and statistical analyses
For linear regression analysis, we first performed a uni-
variate analysis, followed by multivariate modeling intro-
ducing all the variables, in an exploratory fashion. The
linearity assumption of the linear regression was
checked using a plot of the fitted regression line com-
pared with a locally weighted nonparametric scatterplot
of the outcome variable against the predictor. Homosce-
dasticity was checked by graphing residuals versus pre-
dicted and observed values. Finally, normality of
residuals was checked using boxplots, histograms, and
quantile plots of residuals. Ordinal variables were also
checked for linearity using a nested likelihood ratio test.
Some of our variables displayed heteroscedasticity,
therefore, we repeated the analyses using both the
Huber-White sandwich estimator of variance relaxing
the homoscedasticity assumption and bootstrapped
regressions with 1.000 repetitions. The results of these
analyses were in agreement with the findings of our tra-
ditional regression results, which allowed us to take a
relaxed stance toward the heteroscedastic findings in
some of our models. Standard paired t-tests, chi-
squared, and z-tests for proportions were also used. Sig-
nificance was set at alpha < 0.05. The Stata v10.1 (Stata
Corp, Austin, TX) software was used in all analyses.
Ethics
The Data Protection Officials of the Rikshospitalet
approved the study. All patients gave signed informed
consent for entry of the data into the database and for
the subsequent prospective study.
Results
Baseline clinical characteristics
Of the 390 patients eligible for inclusion in this study
(total group), we obtained complete preoperative- and
follow-up data for 258 patients (66.1%) (study group).
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in Table 1. No significant differences were found
between the groups with respect to baseline clinical
characteristics. Only the 258 patients with complete
data sets were included in the analyses.
Pain relief after surgery
We found a significant reduction in radicular pain, neck
pain, and headache after surgery in the study group
(Table 2). The reduction was most pronounced for
radicular pain and neck pain. Using univariate and mul-
tivariate analyses we found that high preoperative pain
intensity was significantly associated with a decrease in
pain intensity after surgery, for all three pain categories.
There were no significant correlations between pain
relief and the following patients characteristics: sex, age,
number of levels fused, disc level fused, fusion method
(AICG versus PEEK-cage), previous neck surgery (except
for neck pain), previous neck trauma, or preoperative
symptom duration (Table 3). As the clinical impact of
Table 1 Patient characteristics.
ACDF Study group
N = 258
Total group
N = 390
p-value
Females - no of patients (%) 114 (44) 178 (46) 0.72
prop
Median age (range) - (years) 47.5 (28.3-82.8) 47.7 (26.9- 82.8) 0.73
Levels per procedure - no of patients (%)
One level 152 (59) 240 (61) 0.50
Two levels 104 (40) 148 (38) 0.55
Three levels 2 (1) 2 (1) 0.68 0.75
c2
Level - no of patients (%)
C3/C4 7 (3) 7 (2) 0.43
C4/C5 38 (15) 56 (14) 0.90
C5/C6 182 (71) 266 (68) 0.53
C6/C7 137 (53) 207 (53) 0.99
C7/Th1 2 (1) 6 (2) 0.39 0.85
c2
Method of fusion - no of patients (%)
Autologous bone graft 181 (70) 278 (71) 0.76
PEEK* cage 77 (30) 112 (29) 0.76 0.76
c2
Symptoms - no of patients (%)
Radiculopathy 206 (80) 309 (79) 0.85
Radiculopathy and myelopathy 36 (14) 50 (13) 0.86
Myelopathy 9 (3) 18 (5) 0.48
No radiculopathy or myelopathy 7 (3) 13 (3) 0.66
Previous ACDF - no of patients (%) 11 (4) 18 (5) 0.83
Previous neck trauma - no of patients (%) 23 (9) 26 (7) 0.29
*Polyetheretherketone
Table 2 Intensity of pain measured using the VAS scale before surgery (preop) and 6 months after surgery (postop).
Paired differences
95% Confidence interval
Paired samples N Mean Mean Lower Upper Sig. (two-tailed)
Preop radicular pain 258 7.47
3.05 2.65 3.45 0.000
Postop radicular pain 258 4.42
Preop neck pain 255 6.45
2.30 1.90 2.71 0.000
Postop neck pain 255 4.15
Preop headache 254 3.63
0.55 0.22 0.89 0.001
Postop headache 254 3.08
(Paired sample t-test).
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mated the number of patients that had changes in VAS
scores of more than ± 2 for the three pain categories
(Table 4). Radicular pain improved ≥ 2 VAS points in 64%
of the patients, while 6% of patients experienced a worsen-
ing of VAS scor ≤ -2. Neck pain improved ≥ 2 VAS points
in 55% of the patients, while 10% of patients experienced a
worsening of VAS score ≤ -2. Headache improved ≥ 2
VAS points in 31% of the patients, while 16% of patients
experienced a worsening of VAS score ≤ -2.
Paresis
One hundred and fifty-one of the 249 (61%) patients
had normal muscular strength at the time of surgery. At
follow-up, 233/249 (94%) patients had normal muscular
strength.
Myelopathy
Of the 45 patients with clinical evident myelopathy at
the time of surgery, only 16 (35.6%) had persistent mye-
lopathy 6 months after surgery.
Table 3 Univariate and multivariate Cox regression model of potential predictors of outcome.
Delta radicular pain Delta neck pain Delta headache
Univariate Multivariate Univariate Multivariate Univariate Multivariate
Sex 0.25
[-0.56, 1.05]
0.031
[-0.73, 0.79]
0.40
[-0.41,1.22]
0.18
[-0.49, 0.85]
0.34
[-0.34, 1.01]
0.15
[-0.45,0.74]
Age -0.035
[-0.08, 0.01]
0
.
0.0095
[-0.03, 0.05]
0
.
-0.000059
[-0.04, 0.04]
0
.
Type of fusion 0.0077
[-0.87, 0.88]
0.21
[-0.61, 1.04]
0.096
[-0.78, 0.98]
-0.069
[-0.79, 0.66]
-0.21
[-0.94, 0.52]
-0.040
[-0.69, 0.61]
No of levels 0.40
[-0.38, 1.19]
0.35
[-0.49, 1.18]
0.23
[-0.56, 1.02]
0.14
[-0.60, 0.87]
0.32
[-0.34, 0.98]
0.37
[-0.28, 1.03]
Level 0.088
[-0.46, 0.64]
0.055
[-0.53, 0.64]
0.35
[-0.20, 0.91]
0.068
[-0.45, 0.58]
0.019
[-0.44, 0.48]
-0.18
[-0.64, 0.28]
Previous symptom duration -0.0019
[-0.01, 0.01]
-0.0016
[-0.01, 0.01]
0.0028
[-0.00, 0.01]
-0.00088
[-0.01, 0.01]
0.0018
[-0.00, 0.01]
-0.0014
[-0.01, 0.00]
Previous neck surgery -0.62
[-2.59, 1.36]
-0.50
[-2.37, 1.36]
-1.75
[-3.73, 0.23]
-1.82*
[-3.45, -0.18]
-1.31
[-3.03, 0.41]
-1.02
[-2.54, 0.51]
Previous neck trauma 0.24
[-1.17, 1.64]
-0.098
[-1.42, 1.23]
-0.58
[-1.99, 0.83]
-0.37
[-1.53, 0.79]
0.011
[-1.16, 1.18]
-0.53
[-1.56,0.51]
Preop radicular pain 0.60***
[0.44, 0.76]
0.63***
[0.45, 0.81]
0.31***
[0.13, 0.48]
-0.030
[-0.19, 0.13]
0.065
[-0.08, 0.21]
-0.021
[-0.16, 0.12]
Preop neck pain 0.14
[-0.00, 0.28]
-0.075
[-0.23, 0.08]
0.66***
[0.54, 0.78]
0.75***
[0.62, 0.89]
0.16**
[0.04, 0.28]
-0.035
[-0.16, 0.09]
Preop headache 0.078
[-0.07,0.22]
0.041
[-0.11, 0.19]
0.087
[-0.06, 0.23]
-0.22**
[-0.35, -0.09]
0.52***
[0.41, 0.62]
0.54***
[0.42, 0.66]
Observations 256 255 252
Adjusted R
2 0.150 0.350 0.261
95% confidence intervals are shown in brackets
p < 0.05, ** p < 0.01, *** p < 0.00
Outcome variables are the paired differences between preoperative and postoperative pain VAS scores (delta radicular pain, delta neck pain and delta headache).
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At the onset of symptomatic CDD, 80% of patients were
employed fulltime, 3% received workers ‘compensation
for CDD, 4% received workers ‘compensation for rea-
sons other than CDD, 8% received a disability pension,
and 5% were students, housewives, retired, or unem-
ployed. At the time of surgery, 66% of patients had
received workers ‘compensation for 1 month or more.
The median sick leave before surgery was 5.0 (0-150)
months. Six months after surgery, 48% of patients had
returned to work: however 24% were still receiving
workers ‘compensation. The percentage of patients
receiving a disability pension increased from 8%, before
the onset of symptomatic CDD, to 21% 6 months post-
operatively. The increase in the number of patients
receiving a disability pension was, related to CDD in all
cases but one.
Patient satisfaction
At the 6-month postoperative control, all patients were
asked to score their satisfaction with the surgical result
using a VAS scale. The mean reported VAS score was
8.42, and 200/256 (78%) patients reported a score > 8
(success). Only 27/256 (11%) patients reported a VAS
score < 5, which indicate that the operation did not ful-
fil their expectations (failure). Patient satisfaction was
then correlated to other measures of surgical outcome
at 6 months (Table 5). Patient satisfaction was signifi-
cantly associated with pain relief after surgery.
Discussion
Symptom relief after ACDF
The effectiveness of ACDF in relieving radicular pain sec-
ondary to CDD is well documented in both long- and
short-term follow-up studies [12,15,28-30]. However, the
effectiveness of ACDF in relieving neck pain and head-
ache secondary to CDD remains unclear. In this prospec-
tive study of 258 patients, we confirmed the beneficial
effect of ACDF on radicular pain. The patients also
reported a significant improvement in their neck pain
and headache. The reduction in headache, although sig-
nificant, was only by 0.55 points on the VAS scale, in
contrast to the changes observed for radicular and neck
pain (VAS score variation of 3.05 and 2.30, respectively).
The clinical impact of changes in VAS scores < 2 is
unclear. An improvement in VAS score ≥ 2 was observed
in 64%, 55%, and 31% of patients, for radicular pain, neck
pain, and headache, respectively. Almost all patients in
our series had radicular pain: therefore, our cohort can-
not be used to answer the question concerning the effect
of ACDF on neck pain or discogenic headache in patients
with mild or no radicular pain. Schofferman et al. pub-
lished a series of nine patients that allowed them to con-
clude that ACDF is an effective treatment for discogenic
headache [31]. In a recent publication, Laimi et al.
reported a low probability of association between head-
ache and CDD [32]. We remain reluctant to offer ACDF
to patients with dominating neck pain or headache who
have little or no radicular pain.
Working status
The percentage of patients that returned to work within
6 months of surgery was lower than expected [28]. The
Table 5 Patient satisfaction 6-months after surgery
correlated with selected preoperative variables and other
measures of surgical outcome at 6 months.
Patient
satisfaction
Sex -0.19
[-0.85, 0.46]
Age -0.031
[-0.07, 0.00]
Previous symptom duration 0.00014
[-0.01, 0.01]
Delta radiculopathy 0.33***
[0.24, 0.42]
Delta neck pain 0.22***
[0.12, 0.31]
Delta headache 0.20**
[0.08, 0.31]
Observations
(Linear univariate regression analysis).
95% confidence intervals are shown in brackets
* p < 0.05, ** p < 0.01, *** p < 0.001
Table 4 Number of patients with changes in VAS scores of more than ± 2 for the three pain categories, radicular pain,
neck pain and headache, separately.
Delta VAS = preoperative - postoperative
Pain category Worsened (≤ -2VAS) Unchanged Improved (≥ 2 VAS)
Radicular pain 16 (6.2%) 78 (30.2%) 164 (63.6%)
Neck pain 26 (10.1%) 91 (35.3%) 141 (54.7%)
Headache 41 (15.9%) 136 (52.7%) 81 (31.4%)
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sistence, passive approach with respect to motivating the
patient to return to work, and that surgery in some
patients was regarded as the last necessary step for the
collection of a permanent disability pension. More effort
is required to assist the return of patients to the work-
place as early as possible. Bhandari et al. reported that
28% of their patient cohort had not returned to work
one year after cervical discectomy [33]. These authors
found that long preoperative sick leave and persistent
postoperative neck pain were associated with not return-
ing to work after surgery. Age and disability claims also
influenced the rates of return to work. Steinmetz et al.
have studied return to work in a cohort of patients who
had workers compensation as their primary insurance.
They found 42% return to work 6 months after ACDF
and 55% return to work 6 months after cervical disc
arthroplasty [34].
Patient satisfaction
Two hundred out of the 256 (78%) patients evaluated
the surgical result as successful. Only 27/256 (11%)
patients classified the surgical result as a failure. A 78%
success rate after surgery for CDD must be regarded as
acceptable. Patient satisfaction is often evaluated using
the Odom Criteria [35]. This said, the VAS scale is an
accepted tool to evaluate patient satisfaction[26].
Prognostic factors
In our series, we found a significant correlation between
high preoperative pain intensity and decrease in pain
intensity after surgery, for all three pain categories. We
found no significant correlation between symptom reduc-
tion after ACDF and sex, age, number of levels fused,
disc level fused, fusion method (AICG or PEEK), previous
neck surgery (except for neck pain), previous neck
trauma or preoperative symptom duration. The most
likely explanation for the lack of identification of prog-
nostic factors is that we selected the best candidates for
surgery based on previous knowledge [4,5]. However we
were surprised by the fact that symptom duration failed
to influence the final surgery outcome, as many of our
patients had a rather long preoperative symptom dura-
tion. This finding is in contrast with earlier reports on
symptomatic CDD and herniated lumbar disc with scia-
tica [6,7]. An unfavorable postoperative outcome was
reported in cases where symptom duration exceeded 6
months in patients treated for herniated lumbar disc and
sciatica [6]. Our data suggest that a lengthy duration of
symptoms does not influence outcomes.
Fusion with PEEK cage versus AICG
Anterior cervical decompression and fusion with auto-
logous bone graft has been the standard treatment for
CDD for more than 50 years [9]. In recent years, many
surgeons have replaced autologous bone grafting with
an artificial cage and they report equivalent clinical
outcomes after this shift in surgical procedure
[12,14-17]. Our study confirmed the results of these
previous studies. We found no significant differences
between the type of fusion in relation to reduction of
radicular pain, neck pain, or headache. We have
reported the presence of similar complication rates for
patients fused with a PEEK cage or with AICG, with
the exeption of the absence of donor site morbidity in
patients fused with a PEEK cage [11]. The absence of
donor site morbidity, the shorter operation time, and
the equivalent clinical results associated with the use of
PEEK cages lead us to prefer this type of fusion to
AICG.
Optimal surgical procedure for CDD
There is no clear consensus regarding the optimal sur-
gical procedure for CDD [2,36-38]. Which procedure
provides the best clinical outcomes: anterior cervical
discectomy alone (ACD), ACDF, discectomy with
intervertebral fusion and instrumentation (ACDFI), or
cervical arthroplasty? A recent prospective randomized
study comparing ACD, ACDF and ACDFI in patients
with CDD showed no significant differences in clinical
outcomes at the 2 year follow up[37]. However,
patients operated with ACD had a higher rate of seg-
mental kyphosis than patients operated with ACDF or
ACDFI. Some authors report lesser graft dislocations
and graft collapse and higher fusion rates after ACDFI
compared with ACDF [13,39,39-42]. On the other
hand, the complication rate after ACDFI is somewhat
higher compared with ACDF [12,13,41]. ACD, ACDF
and ACDFI reduce segmental motion and cause heigh-
tened stress on the discs below and above the fusion,
which in turn may induce adjacent-level degeneration
[43-46]. The main arguments in favor of cervical
arthroplasty are the preservation of segmental motion
and a lower risk of adjacent-level disc degeneration.
The results of randomized, controlled clinical trials
comparing cervical disc arthroplasty with ACDF are
now emerging [45,47-54]. The follow-up times in the
arthroplasty studies are relatively short, however there
is a tendency for slightly improved outcomes after cer-
vical prosthesis compared with ACDF. Our routine
procedure has so far been ACDF, (both single-level
and two-level ACDF). Based on the current literature,
we see no reason to change this strategy at this time,
although we accept that ACD, ACDFI, and prosthesis
probably provide similar clinical outcomes. If the long-
term clinical outcome of cervical arthroplasty is
demonstrated to be superior to ACDF, we will change
our treatment strategy.
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￿ The patients were not randomized to fusion with
either AICG or PEEK-cage. The type of fusion was in
each case decided by the surgeon. This may cause a bias
in the material.
￿ Ideally the outcome after ACDF for CDD should
have been compared with an equivalent group managed
with conservative measures.
￿ The follow-up evaluation was done by the surgeons
and not an independent investigator, this may have
influenced the final result.
Conclusions
￿ ACDF is an effective treatment for radicular pain in
selected patients with CDD (patients evaluated 6 months
after surgery).
￿ Because of similar clinical outcome and lack of
donor site morbidity when using PEEK, we now prefer
fusion with PEEK-cage to AICG.
￿ Lengthy symptom duration was not a negative prog-
nostic marker in our patient population.
￿ The number of patients who returned to work 6
months after surgery was lower than expected.
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